NFE2L2 and neoplasm: Treatment with a dietary dose of SFN can act by mobilizing neutrophils to the primary tumor, simultaneously reducing the blood-circulating granulocytes population through the Nrf2 pathway activation, thereby promoting the elimination of both cancer and metastatic cells.